METHOD OF ENHANCING THE GENE EXPRESSION LEVEL OF TGM1, KRT, AQP3, FLG, GBA, AND HAS USING PLANT EXTRACTS

Abstract

The present invention provides a method of a composition containing plant extracts for enhancing the gene expression level of TGM1, KRT, AQP3, FLG, GBA, and HAS. Compared to a single plant extract, the combination of the plant extracts of the present invention can more effectively enhance the expression level of skin moisturizing genes. The plant extracts constituting the composition include: an extract of spinach, blueberry, Pu-erh tea, or Four Seasons Spring tea.

Claims

1. A method of enhancing expression of transglutaminase 1 (TGM1), keratin (KRT), aquaporin 3 (AQP3), filaggrin (FLG), glucocerebrosidase (GBA), and hyaluronic synthase (HAS) genes, comprising administering to a subject in need thereof a composition comprising an effective amount of a plant extract; wherein the plant extract comprises at least one combination selected from the group consisting of a Pu-erh tea extract and a blueberry extract, a Pu-erh tea extract and a spinach extract, a Four Seasons Spring tea extract and a blueberry extract, and a Four Seasons Spring tea extract and a spinach extract.

2. The method according to claim 1, wherein the KRT gene comprises keratin 1 (KRT1), keratin 10 (KRT10), and keratin 14 (KRT14).

3. The method according to claim 1, wherein the HAS gene comprises hyaluronic synthase 2 (HAS2) and hyaluronic synthase 3 (HAS3).

4. The method according to claim 1, wherein the plant extract comprises at least 0.125 mg/mL of the Pu-erh tea extract and at least 0.125 mg/mL of the spinach extract.

5. The method according to claim 1, wherein the plant extract comprises at least 0.125 mg/mL of the Four Seasons Spring tea extract and at least 0.125 mg/mL of the spinach extract.

6. The method according to claim 1, wherein the plant extract comprises at least 0.25 mg/mL of the Pu-erh tea extract and at least 0.25 mg/mL of the blueberry extract.

7. The method according to claim 1, wherein the plant extract comprises at least 0.25 mg/mL of the Pu-erh tea extract and at least 0.25 mg/mL of the Four Seasons Spring tea extract.

8. The method according to claim 1, wherein the composition promotes skin moisturization.

9. The method according to claim 1, wherein the composition further comprises a pharmaceutical acceptable carrier.

10. The method according to claim 1, wherein the composition is in a form of powder, granule, liquid, gel, or paste.

11. The method according to claim 1, wherein the composition is prepared in a form of a medicament or a food product.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0012] The following drawings form part of the present specification and are included here to further demonstrate some aspects of the present invention, which can be better understood by reference to one or more of these drawings, in combination with the detailed description of the embodiments presented herein.

[0013] FIG. 1 is a diagram showing the moisturizing scores of different plant extracts or combinations.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

[0014] The embodiments of the present invention are further described with the following drawings. The following embodiments are given to illustrate the present invention and are not intended to limit the scope of the present invention, and those having ordinary skill in the art can make some modifications and refinements without departing from the spirit and scope of the present invention. Therefore, the scope of the present invention is defined by the scope of the appended claims.

Definition

[0015] As used herein, the data provided represent experimental values that can vary within a range of 20%, preferably within 10%, and most preferably within 5%.

Example 1 Preparation of Each Plant Extract

1-1 Preparation of Four Seasons Spring Tea Extract

[0016] The Four Seasons Spring tea extract was prepared as follows: first, the leaves of Four Seasons Spring tea plant were washed and dried, and then Four Seasons Spring was coarsely crushed by a pulverizer to be a crude material. The crude material of Four Seasons Spring tea was extracted using water as the solvent. The weight ratio of the solvent to the crude material was 5-20:1-5. The extraction temperature was at 50-100 C., preferably 75-95 C., for 0.5-3 hours to obtain the crude extract of the Four Seasons Spring tea. After the extraction, the crude extraction was cooled to room temperature. The crude extraction was filtered through a 400 mesh filter to remove residual solids. Furthermore, the filtered of the Four Seasons Spring tea was further concentrated under reduced pressure at 45-70 C. to obtain a concentrated product and the concentrated product was the Four Seasons Spring tea extract of the present invention.

1-2 Preparation of Spinach Extract

[0017] The spinach extract was obtained by extracting spinach (Spinacia oleracea), and the spinach extract used in the example was purchased from HONHSIANG farm products factory.

1-3 Preparation of Blueberry Extract

[0018] The blueberry extract was obtained by extracting the fruits of Vaccinium cyanococcus, and the blueberry extract used in the example was purchased from BIOMED HERBAL RESEARCH CO., LTD.

1-4 Preparation of Pu-erh Tea Extract

[0019] The Pu-erh tea extract was obtained by extracting the post-fermented leaves of Camellia sinensis, and the Pu-erh tea extract used in the example was purchased from Nanjing Zelang Biotechnology Co., Ltd.

Example 2 Effects of Combination of the Plant Extracts on Enhancing the Gene Expression Level of TGM1, KRT, AQP3, FLG, GBA, and HAS

[0020] The present invention performed the genetic analysis of TGM1, KRT, AQP3, FLG, GBA, and HAS by human primary epidermal keratinocytes (HPEK). The human primary epidermal keratinocytes were purchased from CELLnTEC (Switzerland) No. HPEK-50, and the cells were cultured in serum-free keratinocyte-SFM (Gibco, Inc., #10724-011, USA).

[0021] First, 1.510.sup.5 of HPEK were seeded in 6-well culture plates containing 2 mL of the above culture medium, and the cells were divided into the following 10 groups with: (1) 0.125 mg/mL of the Pu-erh tea extract, (2) 0.125 mg/mL of the spinach extract, (3) 0.125 mg/mL of the Four Seasons Spring tea extract, (4) 0.125 mg/mL of the combination of the Pu-erh tea extract and the spinach extract mixed in a ratio of 1:1, (5) 0.125 mg/mL of the combination of the Four Seasons Spring tea extract and the spinach extract mixed in a ratio of 1:1, (6) 0.25 mg/mL of the Pu-erh tea extract, (7) 0.25 mg/mL of the blueberry extract, (8) 0.25 mg/mL of the Four Seasons Spring tea extract, (9) 0.25 mg/mL of the combination of the Pu-erh tea extract and the blueberry extract mixed in a ratio of 1:1, and (10) 0.25 mg/mL of the combination of the Four Seasons Spring tea extract and the blueberry extract mixed in a ratio of 1:1; wherein, the cells treated without any extract was as the blank control group. After added the plant extracts of the above groups, the cells were stimulated by each group of the plant extracts at 37 C. The culture medium of each group was changed with fresh one added with each group of the specific plant extracts after 6 and 24 hours of culture respectively. Next, cells were lysis with lysis buffer, and then the total RNAs of cells were collected from the each of the ten groups by the RNA extraction kit (purchased from Geneaid, Taiwan, Lot No. FC24015-G). Then, 2000 ng of extracted RNAs was subjected as the template to reverse transcription into the corresponding cDNA products of the specific mRNAs with SuperScript III reverse transcriptase (purchased from Invitrogene, USA, number 18080-051). Then, the cDNA products of these 10 groups were used as template and mixed with the primers of the target gene in Table 1 and the mRNA expression level of TGM1, KRT1, KRT10, KRT14, AQP3, FLG, GBA, HAS2, and HAS3 of each group were quantified by quantitative real-time polymerase chain reaction (qPCR) with ABI StepOnePlus Real-Time PCR System (Thermo Fisher Scientific, USA) and KAPA SYBR FAST qPCR Kits (purchased from Sigma, USA, No. 38220000000), wherein the PCR conditions were performed as described below: 40 PCR cycles of 95 C. for 1 sec and 60 C. for 20 secs. Wherein, the quantitative value was taken from the cycle threshold (Ct), and the relative amount of mRNA of the target gene was derived from Equation 2.sup.ct, wherein Ct=Ct.sub.target gene-Ct.sub.ACTB (-actin). Then, the SCORE method was used to quantify the scores of each gene expression levels in the above ten groups. The scores of each gene was summed as the moisturizing scores of each group, wherein the SCORE method was calculated using the loop threshold of the ACTB gene and the reference gene (the corresponding gene in the blank control group).

TABLE-US-00001 TABLE 1 The sequence of the PCR primer Gene Primer Number Primer length (ntds) TGM1 TGM1-F SEQ ID NO: 1 22 TGM1-R SEQ ID NO: 2 19 KRT1 KRT1-F SEQ ID NO: 3 21 KRT1-R SEQ ID NO: 4 21 KRT10 KRT10-F SEQ ID NO: 5 22 KRT10-R SEQ ID NO: 6 19 KRT14 KRT14-F SEQ ID NO: 7 20 KRT14-R SEQ ID NO: 8 20 AQP3 AQP3-F SEQ ID NO: 9 19 AQP3-R SEQ ID NO: 10 21 FLG FLG-F SEQ ID NO: 11 20 FLG-R SEQ ID NO: 12 20 GBA GBA-F SEQ ID NO: 13 20 GBA-R SEQ ID NO: 14 20 HAS2 HAS2-F SEQ ID NO: 15 23 HAS2-R SEQ ID NO: 16 20 HAS3 HAS3-F SEQ ID NO: 17 19 HAS3-R SEQ ID NO: 18 21 -actin ACTB-F SEQ ID NO: 19 21 ACTB-R SEQ ID NO: 20 21

[0022] The moisturizing scores of each combination of the plant extracts of the present invention was shown in Table 2 and FIG. 1; wherein, the higher the moisturizing scores, the better the promotion of the skin moisturization. Previous studies have indicated that transglutaminase 1 (TGM) forms a strong bond between the cell membrane of keratinocytes and structural proteins, and then increases the strength and stability of the epidermal layer; keratin (KRT) forms keratin microfilaments, and filaggrin (FLG) helps keratin microfilaments assemble into a strong network that provides strength and elasticity to the skin; aquaporin (AQP) increases the permeability of water in keratinocytes to increase the water content of keratinocytes; hyaluronic synthase (HAS) promotes the ability of keratinocytes to secrete hyaluronic acid, and then makes the structure of the stratum corneum intact and enhances the skin barrier function, which can make the skin retain moisturizing; and Glucocerebrosidase (GBA) is associated with integrity maintaining the structure of keratinous. The moisturizing scores obtained by treating keratinocytes with 0.125 mg/mL of the Pu-erh tea extract, the Four Seasons Spring tea extract, and the spinach extract alone were 2.16, 4.2, and 2.04, respectively. However, the moisturizing scores obtained by treating keratinocytes with 0.125 mg/mL of the combination of the Pu-erh tea extract and the spinach extract mixed in a ratio of 1:1; and with 0.125 mg/mL of the combination of the Four Seasons Spring tea extract and the spinach extract mixed in a ratio of 1:1 were 7.2 and 10.2, respectively; the moisturizing scores obtained by treating keratinocytes with 0.25 mg/mL of the Pu-erh tea extract, the Four Seasons Spring tea extract, the blueberry extract were 3.5, 3.8, and 4.7, respectively; however, the moisturizing scores obtained by treating keratinocytes with 0.25 mg/mL of the combination of the Pu-erh tea extract and the blueberry extract mixed in a ratio of 1:1; and with 0.25 mg/mL of the combination of the Four Seasons Spring tea extract and the blueberry extract mixed in a ratio of 1:1 were 7.4 and 6.6, respectively. The results indicate that the composition comprising a combination of the Pu-erh tea extract and the blueberry extract, the Pu-erh tea extract and the spinach extract, the Four Seasons Spring tea extract and the blueberry extract, or the Four Seasons Spring tea extract and the spinach extract was quite effective in enhancing the expression of the skin moisturizing genes, and could more effectively enhance the gene expression level of TGM1, KRT1, KRT10, KRT14, AQP3, FLG, GBA, HAS2, and HAS3 than the Pu-erh tea extract alone, the Four Seasons Spring tea extract alone, the spinach extract alone, and the blueberry extract alone to more effectively maintain the keratinocyte arrangement of the skin, make the stratum corneum layer structure intact, enhance the skin barrier function, and make the skin produce more moisturizing factors.

TABLE-US-00002 TABLE 2 The moisturizing scores of the expression of the skin moisturization-related genes calculated for each group Plant extracts/ Moisturizing Combinations Concentration/Ratio scores Pu-erh tea 0.125 mg/mL 2.16 Pu-erh tea + Spinach 0.125 mg/mL (1:1) 7.2 Spinach 0.125 mg/mL 2.04 Four Seasons Spring tea + Spinach 0.125 mg/mL (1:1) 10.2 Four Seasons Spring tea 0.125 mg/mL 4.2 Pu-erh tea 0.25 mg/mL 3.5 Pu-erh tea + Blueberry 0.25 mg/mL (1:1) 7.4 Blueberry 0.25 mg/mL 4.7 Four Seasons Spring tea + 0.25 mg/mL (1:1) 6.6 Blueberry Four Seasons Spring tea 0.25 mg/mL 3.8

[0023] In summary, the composition of the present invention containing a combination of the Pu-erh tea extract and the blueberry extract, the Pu-erh tea extract and the spinach extract, the Four Seasons Spring tea extract and the blueberry extract, or the Four Seasons Spring tea extract and the spinach extract can produce an unexpected multiplication effect that can significantly enhance the expression level of the skin moisturizing genes compared with the Pu-erh tea extract alone or the Four Seasons Spring tea extract alone to more effectively maintain the keratinocyte arrangement of the skin, make the stratum corneum layer structure intact, enhance the skin barrier function, and make the skin produce more moisturizing factors.

[0024] Furthermore, the composition containing plant extracts of the present invention for enhancing a gene expression level of transglutaminase 1, keratin, aquaporin 3, filaggrin, glucocerebrosidase, and hyaluronic synthase can be further added to a food, a health food, a dietary supplement, or a drink. Besides, the composition of the present invention can be prepared to be a pharmaceutical composition, and the pharmaceutical composition can be further added to a carrier or other adjuvant well known in the art. The dosage form of the pharmaceutical composition can be, but is not limited to, a solution, a capsule, or a lozenge.